Literature DB >> 2956090

Structural variants of human T200 glycoprotein (leukocyte-common antigen).

S J Ralph, M L Thomas, C C Morton, I S Trowbridge.   

Abstract

Structural variation in the primary structure of human T200 glycoprotein has been detected. Three cDNA variants have been characterized each of which encode T200 molecules that differ in size as a result of sequence differences in their amino-terminal regions. The largest form of the molecule is distinguished from the smallest by an insert of 161 amino acids, after the first eight amino-terminal residues. The other variant has an insert at the same location of 47 amino acids identical to residues 75-121 in the larger insert. Both extra domains are rich in serine and threonine residues and are likely to display multiple O-linked oligosaccharides. These structural variants which probably arise by cell-type-specific alternative splicing provide a molecular basis for the previously observed structural and antigenic heterogeneity of T200 glycoprotein. In addition to the variable amino-terminal region, the external domain of human T200 glycoprotein consists of a second cysteine-rich region of about 400 amino acids, a single transmembrane-spanning region and a large cytoplasmic domain of 707 amino acids shared by all of the structural variants and highly conserved between species. The gene encoding human T200 is located on the long arm of chromosome 1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956090      PMCID: PMC553926          DOI: 10.1002/j.1460-2075.1987.tb02361.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Cloning of human hematopoietic cell lines.

Authors:  T Imamura; C C Huang; J Minowada; M Takahashi; G E Moore
Journal:  J Natl Cancer Inst       Date:  1970-04       Impact factor: 13.506

2.  Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes.

Authors:  C A Sunderland; W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1979-02       Impact factor: 5.532

Review 3.  Molecular biology of fibronectin.

Authors:  R Hynes
Journal:  Annu Rev Cell Biol       Date:  1985

4.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.

Authors:  U Schneider; H U Schwenk; G Bornkamm
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

7.  Quantitative serological analysis of a rabbit anti-rat lymphocyte serum and preliminary biochemical characterisation of the major antigen recognised.

Authors:  J W Fabre; A F Williams
Journal:  Transplantation       Date:  1977-04       Impact factor: 4.939

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Interspecies spleen-myeloma hybrid producing monoclonal antibodies against mouse lymphocyte surface glycoprotein, T200.

Authors:  I S Trowbridge
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

10.  Human homologue of murine T200 glycoprotein.

Authors:  M B Omary; I S Trowbridge; H A Battifora
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  78 in total

1.  Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies.

Authors:  M N McCall; D M Shotton; A N Barclay
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

2.  PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients.

Authors:  Eleonora Cocco; Maria Rita Murru; Cristina Melis; Lucia Schirru; Elisabetta Solla; Marina Lai; Marcella Rolesu; Maria Giovanna Marrosu
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

3.  Amino acids bracketing the predicted transmembrane domains of membrane proteins.

Authors:  C Pidgeon; R L Williard; S C Schroeder
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

4.  Approaches to the molecular cloning of protein-tyrosine phosphatases in insulin-sensitive tissues.

Authors:  B J Goldstein; W R Zhang; N Hashimoto; C R Kahn
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

5.  The human transmembrane secretory component (poly-Ig receptor): molecular cloning, restriction fragment length polymorphism and chromosomal sublocalization.

Authors:  P Krajci; K H Grzeschik; A H Geurts van Kessel; B Olaisen; P Brandtzaeg
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

6.  CD45 enhances positive selection and is expressed at a high level in large, cycling, positively selected CD4+CD8+ thymocytes.

Authors:  C J Ong; J P Dutz; D Chui; H S Teh; J D Marth
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

7.  Identification, cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1.

Authors:  M X Gu; J D York; I Warshawsky; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

8.  CD8+ T-cell clones deficient in the expression of the CD45 protein tyrosine phosphatase have impaired responses to T-cell receptor stimuli.

Authors:  C T Weaver; J T Pingel; J O Nelson; M L Thomas
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

Review 9.  C4b-binding protein, a regulatory protein of complement.

Authors:  S R Barnum
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

10.  The development of primed/memory CD8+ lymphocytes in vitro and in rejecting kidneys after transplantation.

Authors:  A N Akbar; P L Amlot; A Timms; G Lombardi; R Lechler; G Janossy
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.